INTERNATIONAL PATENT: KITE PHARMA, INC. FILES APPLICATION FOR "SYSTEMS AND METHODS FOR UPREGULATION OF LOW-DENSITY LIPOPROTEIN RECEPTOR (LDL-R) EXPRESSION"

GENEVA, July 3 -- KITE PHARMA, INC. (2400 BroadwaySanta Monica, California 90404) filed a patent application (PCT/US2024/061010) for "SYSTEMS AND METHODS FOR UPREGULATION OF LOW-DENSITY LIPOPROTEIN RECEPTOR (LDL-R) EXPRESSION" on Dec 19, 2024. With publication no. WO/2025/137262, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LI, Maolu (Kite Pharma, Inc.c/o Gilead Sciences, Inc.333 Lakeside DriveFoster City, California 94404), JIANG, Kaiyuan (350 Village DriveUnit 1341King of Prussia, Pennsylvania 19406), YIP, Thanh Nguy...